A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Analysis of Fucosylated Human Milk Trisaccharides in Biotechnological Context Using Genetically Encoded Biosensors

5.9K views

⸱

DOI:

10.3791/59253

⸱

April 13th, 2019

 , 

In This Article

Summary

We describe here the high-throughput detection and quantification of fucosylated human milk oligosaccharides (HMOs) using a whole-cell biosensor. We also demonstrate here, the adaptation of this platform towards analysis of HMO production strains, focusing on improving the signal to noise ratio.

Abstract

Human milk oligosaccharides (HMOs) are complex carbohydrate components of human breast milk that exhibit plentiful benefits on infant health. However, optimization of their biotechnological synthesis is limited by the relatively low throughput of detection and quantification of monosaccharide and linkages. Conventional techniques of glycan analysis include chromatographic/mass-spectrometric methods with throughput on the order of hundreds of samples per day without automation. We demonstrate here, a genetically encoded bacterial biosensor for the high-throughput, linkage-specific detection and quantification of the fucosylated HMO structures, 2’-fucosyllactose and 3-fucosyllactose, which we achieved via heterologous expression of fucosidases. As the presence of lactose in milk or in biotechnological processes could lead to false positives, we also demonstrate the reduction of signal from lactose using different strategies. Due to the high throughput of this technique, many reaction conditions or bioreactor parameters could be assayed in parallel in a matter of hours, allowing for the optimization of HMO manufacturing.

Introduction

Human milk oligosaccharides (HMOs) are lactose-derived oligosaccharides, usually comprising three to eight sugar monomers. They have a lactose (Gal-β1,4-Glc) reducing end and are further elongated by glycosidic links (β-1,3- or β-1,6-) to glucose (Glc), galactose (Gal), or N-acetylglucosamine (GlcNAc). In addition, fucose (Fuc, α-1,2- or α-1,3-) or sialic acid (Sia or NeuAc, α-2,3- or α-2,6-) residues are often added1.

Current analysis of oligosaccharides and other carbohydrates is limited in throughput and scope by the need for chromatographic/mass spectrometric (MS) technology

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Cell culture and induction conditions

NOTE: In the following experiments, three strains are used: E. coli BL21 (DE3) with an empty vector, E. coli BL21 (DE3) with plasmids pAfcA14 and pET28:green fluorescent protein (GFP), and E. coli BL21 (DE3) with plasmids pAfcB14 and pET28:GFP. All strains are grown in Luria-Bertani broth (LB) or minimal media with appropriate antibiotics. Prepare stock solutions of 1,000x kanamycin (50 mg/mL) and carbenicillin (100 mg/mL) in deionized (DI) water.

  1. Media preparation
    1. Prepare LB media by adding 25 g of LB powder st....

Access restricted. Please log in or start a trial to view this content.

Results

We designed a whole cell biosensor specific to 2’-FL that can be used in conjunction with the biotechnological production of the oligosaccharide. This relies on the specific enzymatic cleavage of modifying terminal sugars generating lactose and thereby activation of the lac operon, leading to expression of a reporter fluorescent protein under a lactose inducible promoter, in proportion to the quantity of 2’-FL. To demonstrate its linkage specificity, 3-fucosyllactose (3-FL), an i.......

Access restricted. Please log in or start a trial to view this content.

Discussion

We present a high-throughput strategy for the linkage-specific detection of fucosylated human milk oligosaccharides. This was accomplished by building whole cell biosensors by genetically engineering E. coli which upon induction with specific glycans respond with a fluorescent signal. The protocol also details on how the biosensor can be used to detect and quantify HMOs in a metabolically engineered bacterial strain.

Our protocol offers advantages over alternative methods due to its h.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work was supported by Iowa State University Startup Funds. F.E. was partially funded by the NSF Trinect Fellowship and Manley Hoppe Professorship. ­­T.J.M. was partially supported by the Karen and Denny Vaughn Faculty Fellowship. The authors thank the Iowa State University Flow Cytometry Facility and the W.M. Keck Metabolomics Research Laboratory for assistance with fluorescence and LC-MS studies.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
2’-Fucosyllactose Carbosynth 41263-94-9
3-Fucosyllactose Carbosynth 41312-47-4
AgarFisher ScientificBP9744500
Calcium Chloride, DihydrateFisher ScientificC79-500
Carbenicillin Fisher ScientificBP26481
Dextrose (D-Glucose), AnhydrousFisher ScientificD16-1
Flow CytometerBDFACSCanto Plus RUO
HPLCAgilent Technologies1100 Series HPLC system
HPLC ColumnLunaC18 reversed phase column
KanamycinFisher Scientific11815024
LB Broth, Miller Fisher Scientific12-795-027
LactoseFisher Scientific64044-51-5
M9, Minimimal Salts, 5xSigma-AldrichM6030
Magnesium Sulfate, AnhydrousFisher ScientificM65-500
MSAgilent TechnologiesMass Selective Trap SL detector
Sodium chlorideSigma-Aldrich7647-14-5
Sodium phosphate dibasicSigma-Aldrich7558-79-4
Sodium phosphate monobasicSigma-Aldrich13472-35-0

References

  1. Ninonuevo, M. R., et al. A strategy for annotating the human milk glycome. Journal of Agricultural and Food Chemistry. 54 (20), 7471-7480 (2006).
  2. Kailemia, M. J., Ruhaak, L. R., Lebrilla, C. B., Amster, I. J. Oligosaccharide analysis by mass ....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Fucosylated HMOsBiosensor DetectionFlow CytometryHigh-Throughput ScreeningLactose InterferenceBeta GalactosidaseGenetic EngineeringE.Coli ExpressionOligosaccharide QuantificationLinkage Specificity